• ADMA Biologics Inc average return on tangible equity for 2023 was -26.12, a 58.11% decline from 2022.
• ADMA Biologics Inc average return on tangible equity for 2022 was -62.35, a 20.14% decline from 2021.
• ADMA Biologics Inc average return on tangible equity for 2021 was -78.07, a 29.54% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.